Partial Victory For Pfizer In Xalatan Suit Vs. Par
In a July 6 decision, Judge Stanley R. Chesler of the US. District Court for the District of New Jersey held that Pharmacia's patent on formulations and uses of latanoprost (U.S. 5,296,504, expiring in March 2011) was valid, infringed and enforceable against Par.
The judge issued an injunction blocking the approval of Par's drug application until the March 2011 expiration...
To view the full article, register now.